U.S. IPOs for life sciences companies

News

Trump Administration Executive Order (EO) Tracker

Are you a life sciences company looking to go public in the future? Join us for a webinar on Tuesday, 25 February 2025, tailored specifically for German-based life sciences companies considering a U.S. initial public offering.

Our webinar will provide invaluable insights on key considerations and strategic decisions for life sciences companies exploring a U.S. IPO and will help you answer questions such as:

Is an IPO the right move?

Why might the U.S. be the best market?

NASDAQ or NYSE: which is the right exchange for us?

What are the key financial and operational benchmarks we’ll need to meet for a successful IPO?

What consequences will U.S. listed-company rules have for our corporate governance?

We will also explain the SEC registration process; listing structures such as SPACs, direct listings, and traditional IPOs; how leveraging a Netherlands vehicle can support cross-border success; the life sciences-specific issues that arise in a U.S. IPO; and ongoing compliance obligations.

Our webinar will also delve into the complex regulatory environment and provide a roadmap for the essential workstreams needed to achieve a smooth and efficient IPO process.

This session is designed for executives, founders, and decision-makers in life sciences companies looking to raise capital, accelerate growth and expand in the U.S. market. Our distinguished speakers include seasoned legal, financial, and industry experts with extensive experience in U.S. IPOs and life sciences.

We look forward to welcoming you to this session.

U.S. IPOs for life sciences companies

Please click here for your registration.